Macrogenics (MGNX) Misses Q2 EPS by 23c
Tweet
Share
E-mailGet Alerts MGNX Hot Sheet
Join SI Premium – FREE
Macrogenics (NASDAQ: MGNX) reported Q2 EPS of ($0.89), $0.23 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $10.79 million versus the consensus estimate of $20.94 million.
For earnings history and earnings-related data on Macrogenics (MGNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
- Cerebras CEO says investors misunderstood margin guidance
- Freedom Capital Starts Klarna (KLAR) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
